PUBLIC COMPANY
saveAPIE Therapeutics Inc
founded 2020 · Cary, NC, USupdated 1mo ago
APIE Therapeutics is a preclinical biotech developing small-molecule apelin receptor (APJ) agonists for fibrotic diseases. Its lead candidate, APT-101, has received FDA Orphan Drug Designation for idiopathic pulmonary fibrosis and is also being advanced for systemic sclerosis-associated interstitial lung disease. The company was spun out of a 2020 licensing agreement with RTI International and is based in Cary, North Carolina.
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Preclinical
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
comments(0)
5-min edit window · permanent after that